These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2832054)

  • 1. Augmentation of postconfluence growth arrest of 10T1/2 fibroblasts by endogenous cyclic adenosine 3':5'-monophosphate.
    Matsukawa T; Bertram JS
    Cancer Res; 1988 Apr; 48(7):1874-81. PubMed ID: 2832054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
    Bertram JS; Faletto MB
    Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of cellular interactions between C3H/10T1/2 cells and their transformed counterparts by phosphodiesterase inhibitors.
    Bertram JS
    Cancer Res; 1979 Sep; 39(9):3502-8. PubMed ID: 89899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
    Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
    J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
    Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ; Liu H; Palmer D; Maurice DH
    Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
    Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
    Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human mammary carcinoma cell proliferation by retinoids and intracellular cAMP-elevating compounds.
    Fontana JA; Miksis G; Miranda DM; Durham JP
    J Natl Cancer Inst; 1987 Jun; 78(6):1107-12. PubMed ID: 3035264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the adenosine 3',5'-cyclic monophosphate (cAMP) in enhancing the efficacy of siRNA-mediated gene silencing in neuroblastoma cells.
    Hanson AJ; Nahreini P; Andreatta C; Yan XD; Prasad KN
    Oncogene; 2005 Jun; 24(25):4149-54. PubMed ID: 15806165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cyclic-AMP on arginase activity by a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans.
    Sosroseno W; Musa M; Ravichandran M; Fikri Ibrahim M; Bird PS; Seymour GJ
    Oral Microbiol Immunol; 2006 Dec; 21(6):347-52. PubMed ID: 17064391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modulation of apoptosis by cyclic AMP involves Akt and epidermal growth factor receptor.
    Zhou B; Li F; Chen H; Song J
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1483-95. PubMed ID: 15833279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
    Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
    Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of keratin intermediate filament distribution in vivo by induced changes in cyclic AMP-dependent phosphorylation.
    Eckert BS; Yeagle PL
    Cell Motil Cytoskeleton; 1990; 17(4):291-300. PubMed ID: 1706224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine cumulus cell-oocyte gap junctional communication during in vitro maturation in response to manipulation of cell-specific cyclic adenosine 3',5'-monophosophate levels.
    Thomas RE; Armstrong DT; Gilchrist RB
    Biol Reprod; 2004 Mar; 70(3):548-56. PubMed ID: 14568915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cells.
    Leitman DC; Fiscus RR; Murad F
    J Cell Physiol; 1986 May; 127(2):237-43. PubMed ID: 3009497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells.
    Aharoni D; Dantes A; Oren M; Amsterdam A
    Exp Cell Res; 1995 May; 218(1):271-82. PubMed ID: 7537693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
    Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
    Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.